Kidney Cancer - Causes, Symptoms, Risks Factors and More

Kidney cancer or renal carcinoma usually occurs in older people and accounts for about 2 to 3% of cancers in adults, affecting about twice as many men as women. In adults, the most common type of kidney tumor is renal cell carcinoma, which begins in the cells that line the small tubes within your kidneys. Kidney cancer rarely strikes children and young adults; the exceptions are a pediatric kidney cancer called Wilms tumor and some forms of hereditary kidney cancer syndromes, such as von Hippel-Lindau disease.

Start Of Phase 2 Study Of ACE-011 In Patients With Multiple Myeloma

Celgene Corporation (NASDAQ:CELG) and Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced the initiation of a Phase 2 clinical study of its lead compound ACE-011 in patients with multiple myeloma. ACE-011 is being developed to treat bone loss associated with multiple myeloma and other cancers. Complete news at...

Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, and Specialised Therapeutics Australia Pty Ltd, today announced that approval has been received from the Therapeutic Goods Administration (TGA) in Australia to market ABRAXANE® (nanoparticle albumin-bound paclitaxel) 100 mg powder for injection (suspension) for the treatment of metastatic carcinoma of the breast after failure of anthracycline therapy. Complete news at...

Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that it has initiated a Phase 1/2 study of RDEA119, its lead mitogen-activated ERK kinase (MEK) inhibitor for the treatment of cancer, in combination with Nexavar, which is currently approved for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinoma. Complete news at...